Inotiv Inc

Inotiv Inc is a contract research organization (CRO) that provides nonclinical and analytical drug discovery and development services, primarily to the pharmaceutical and medical device industries. The company also sells research-quality animals and diets to these industries, as well as to academia and government clients. Inotiv's services and products support the discovery and preclinical phases of drug and medical device development, and in some cases, the clinical phases. The company aims to increase efficiency, improve data, and reduce costs in bringing new drugs and medical devices to market. Inotiv operates through two reportable segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DSA segment offers discovery and translational sciences, and safety assessment services. These services include nonclinical development and, in certain cases, clinical development, supporting researchers and clinicians primarily for small molecule drug candidates, biotherapeutics, and biomedical devices. These services are conducted utilizing both Good Laboratory Practice (GLP) and non-GLP standards. Inotiv began operating in 1975 as Bioanalytical Systems, Inc., which was incorporated in 1974 and completed an initial public offering in 2000. On March 18, 2021, the company changed its corporate name to Inotiv, Inc. Its stock is traded on The Nasdaq Stock Market LLC under the symbol "NOTV." Inotiv is headquartered in West Lafayette, Indiana, with a mailing address of 2701 Kent Avenue, West Lafayette, Indiana 47906, and a telephone number of (765) 463-4527.